⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging
prnewswire.com
PFE
ABBV
GSK
BMY
Blueroot Health Appoints Jay Schwartz CEO as North Castle Backs Next Phase of Practitioner-Focused Growth
globenewswire.com
PFE
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
prnewswire.com
ARVN
PFE
President Trump Launches TrumpRx.gov to Bypass PBMs and Lower Drug Prices After White House-Requested Proposal by Professor Sarfaraz Niazi
prnewswire.com
PFE
Pfizer Becomes Newest Partner Added to BaseLaunch's Biotech Venture Incubator
prnewswire.com
PFE
ABBV
NVO
JNJ
CSL
CRL
KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer
globenewswire.com
PFE
Longwood Healthcare Leaders to Host Senior Pharma and Biotech Leaders at Annual Leadership Summit, Miami CEO
accessnewswire.com
BLCO
PFE
LLY
CSL
GSK
INCY
JNJ
OVID
EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights
globenewswire.com
PFE
$12 Bn Private LTE/5G Network Market Forecasts, 2025-2026 & 2030: Insights from 35 New Executive Interviews with Market Leading Companies
globenewswire.com
ERIC
NOK
MSFT
AMZN
SWKS
AVGO
QCOM
INTC
CSCO
HPE
SNPS
AMAT
LRCX
KLAC
ASML
MU
WDC
SE
NVDA
AMD
MRVL
NXPI
QRVO
ON
ADI
TXN
MCHP
INFY
IBM
ORCL
SAP
ACN
CTAS
CDNS
GLW
AVNT
ATOS
NTES
BABA
JD
PDD
IQ
BIDU
HTHT
BILI
VIPS
NIO
LI
XPEV
RIVN
LCID
TSLA
F
GM
STLA
CHPT
PLTR
SNOW
DDOG
CRM
NOW
PANW
FTNT
ZS
CRWD
MDB
PYPL
COIN
UPST
SOFI
AFRM
HOOD
ETSY
GOOG
HPQ
DELL
SMCI
ALGN
IDXX
REGN
VRTX
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
BIIB
AZN
SNY
TEVA
BMRN
EXPE
BKNG
MAR
H
IHG
WYNN
LVS
MGM
CCL
RCL
NCLH
AAL
DAL
UAL
LUV
BA
GD
LMT
RTX
HON
CAT
DE
GE
MMM
ROK
EMR
ILMN
MELI
ADBE
GOOGL
AAPL
T
VZ
TMUS
CMCSA
CHTR
Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
GSK
SCYX
PFE
MRK
CDTX
AMPH
ASTX